Affymetrix, Inc.
Genospectra takes a commercial license to bead patents
Published in Medicine and Law Weekly, December 10th, 2004
The license is for research use only.
"We are pleased to have gained access to important parts of Affymetrix' patent portfolio in this area," said Dr. Frank Witney, president and CEO of Genospectra. "Affymetrix's work in this field may be synergistic with QuantiGene and QuantiGene-Plex, our proprietary signal amplification products that offer robust and precise RNA quantification directly from cell lysates or tissue homogenates."
Affymetrix's expanded...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medicine and Law Weekly
More Articles from Medicine and Law Weekly
- Accredo Health, Incorporated
Biotech company comments on CMS Remodulin reimbursement change - Albert Einstein College of Medicine
Immunoglobulin against Cryptococcus glucuronoxylomannan is protective - Applied Biosystems
U.S. Patent issued for nucleic acid amplification device for biological research - Business Update
IPRO to perform reconsiderations of denied Medicare fee-for-service claims - CTI Molecular Imaging, Inc.
Imaging company comments on final APC rates for 2005 - California Department of Social Services
California social services announces 'surrendered baby' awareness campaign - More from this issue of Medicine and Law Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
